Publications by authors named "Ben Markman"

25Publications

Impact of Radiotherapy on the Efficacy and Toxicity of anti-PD-1 Inhibitors in Metastatic NSCLC.

Clin Lung Cancer 2020 Jun 10. Epub 2020 Jun 10.

Department of Medical Oncology, Monash Health, Clayton, Melbourne, Australia; School of Clinical Sciences, Monash University, Melbourne, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2020.06.001DOI Listing
June 2020

Duration of dexamethasone administration for the prevention of chemotherapy-induced nausea and vomiting - A systematic review and meta-analysis.

Crit Rev Oncol Hematol 2020 Aug 2;152:103012. Epub 2020 Jun 2.

Monash Health, Victoria, Australia; Monash University, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2020.103012DOI Listing
August 2020

A phase IIa study of HA-irinotecan, formulation of hyaluronic acid and irinotecan targeting CD44 in extensive-stage small cell lung cancer.

Invest New Drugs 2018 04 26;36(2):288-298. Epub 2017 Dec 26.

Centre for Cancer Research, Hudson Institute of Medical Research, 27-31 Wright Street, Clayton, VIC, 3168, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-017-0555-8DOI Listing
April 2018

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016.

Authors:
Christian Dittrich Michael Kosty Svetlana Jezdic Doug Pyle Rossana Berardi Jonas Bergh Nagi El-Saghir Jean-Pierre Lotz Pia Österlund Nicholas Pavlidis Gunta Purkalne Ahmad Awada Susana Banerjee Smita Bhatia Jan Bogaerts Jan Buckner Fatima Cardoso Paolo Casali Edward Chu Julia Lee Close Bertrand Coiffier Roisin Connolly Sarah Coupland Luigi De Petris Maria De Santis Elisabeth G E de Vries Don S Dizon Jennifer Duff Linda R Duska Alexandru Eniu Marc Ernstoff Enriqueta Felip Martin F Fey Jill Gilbert Nicolas Girard Andor W J M Glaudemans Priya K Gopalan Axel Grothey Stephen M Hahn Diana Hanna Christian Herold Jørn Herrstedt Krisztian Homicsko Dennie V Jones Lorenz Jost Ulrich Keilholz Saad Khan Alexander Kiss Claus-Henning Köhne Rainer Kunstfeld Heinz-Josef Lenz Stuart Lichtman Lisa Licitra Thomas Lion Saskia Litière Lifang Liu Patrick J Loehrer Merry Jennifer Markham Ben Markman Marius Mayerhoefer Johannes G Meran Olivier Michielin Elizabeth Charlotte Moser Giannis Mountzios Timothy Moynihan Torsten Nielsen Yuichiro Ohe Kjell Öberg Antonio Palumbo Fedro Alessandro Peccatori Michael Pfeilstöcker Chandrajit Raut Scot C Remick Mark Robson Piotr Rutkowski Roberto Salgado Lidia Schapira Eva Schernhammer Martin Schlumberger Hans-Joachim Schmoll Lowell Schnipper Cristiana Sessa Charles L Shapiro Julie Steele Cora N Sternberg Friedrich Stiefel Florian Strasser Roger Stupp Richard Sullivan Josep Tabernero Luzia Travado Marcel Verheij Emile Voest Everett Vokes Jamie Von Roenn Jeffrey S Weber Hans Wildiers Yosef Yarden

ESMO Open 2016 29;1(5):e000097. Epub 2016 Sep 29.

Department of General Medical Oncology , University Hospitals Leuven , Leuven , Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2016-000097DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070299PMC
September 2016

Phase I safety, pharmacokinetic, and pharmacodynamic study of SAR245409 (XL765), a novel, orally administered PI3K/mTOR inhibitor in patients with advanced solid tumors.

Clin Cancer Res 2014 May 28;20(9):2445-56. Epub 2014 Feb 28.

Authors' Affiliations: South Texas Accelerated Research Therapeutics, San Antonio, Texas; Memorial Sloan-Kettering Cancer Center, Memorial Hospital, New York, New York; Sanofi, Cambridge, Massachusetts; Exelixis Inc., South San Francisco, California; Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan; Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain; Monash Institute of Medical Research, Monash University, Melbourne, Victoria, Australia; and Sanofi, Vitry-sur-Seine, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-2403DOI Listing
May 2014

PI3K pathway inhibitors: better not left alone.

Curr Pharm Des 2013 ;19(5):895-906

Monash Medical Centre, Southern Health, Melbourne, Australia 3165.

View Article

Download full-text PDF

Source
July 2013

Application of monoclonal antibodies as cancer therapy in solid tumors.

Curr Clin Pharmacol 2012 May;7(2):137-45

Medical Oncology Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/157488412800228929DOI Listing
May 2012

Targeting the PI3K/Akt/mTOR pathway--beyond rapalogs.

Oncotarget 2010 Nov;1(7):530-43

Centre for Cancer Research, Monash Institute of Medical Research, Southern Health, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248125PMC
http://dx.doi.org/10.18632/oncotarget.101012DOI Listing
November 2010

Recent developments in anti-cancer agents targeting PI3K, Akt and mTORC1/2.

Recent Pat Anticancer Drug Discov 2011 May;6(2):210-36

Medical Oncology Service, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Universitat Autonoma de Barcelona, Barcelona, 08035, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/157489211795328503DOI Listing
May 2011

EGFR and KRAS in colorectal cancer.

Adv Clin Chem 2010 ;51:71-119

Medical Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0065-2423(10)51004-7DOI Listing
October 2010

New trends in epidermal growth factor receptor-directed monoclonal antibodies.

Immunotherapy 2009 Nov;1(6):965-82

Medical Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt.09.66DOI Listing
November 2009

Integration of anti-epidermal growth factor receptor therapies with cytotoxic chemotherapy.

Cancer J 2010 May-Jun;16(3):226-34

Medical Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0b013e3181e07670DOI Listing
September 2010

Monoclonal antibodies in solid tumours.

Curr Clin Pharmacol 2010 Aug;5(3):160-5

Medical Oncology Service, Vall d'Hebron University Hospital, P. Vall d'Hebron, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/157488410791498833DOI Listing
August 2010

New approaches and targets in advanced colorectal cancer.

Eur J Cancer 2009 Sep;45 Suppl 1:79-88

Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0959-8049(09)70019-XDOI Listing
September 2009